1. Home
  2. ENTA vs PTLO Comparison

ENTA vs PTLO Comparison

Compare ENTA & PTLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.70

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Logo Portillo's Inc.

PTLO

Portillo's Inc.

HOLD

Current Price

$5.33

Market Cap

433.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
PTLO
Founded
1995
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
486.3M
433.0M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
ENTA
PTLO
Price
$12.70
$5.33
Analyst Decision
Strong Buy
Hold
Analyst Count
5
11
Target Price
$20.40
$8.06
AVG Volume (30 Days)
155.3K
1.4M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
0.27
Revenue
$102,814,000.00
$732,066,000.00
Revenue This Year
$5.91
$9.07
Revenue Next Year
N/A
$6.31
P/E Ratio
N/A
$19.11
Revenue Growth
16.48
3.03
52 Week Low
$4.09
$4.41
52 Week High
$17.15
$13.55

Technical Indicators

Market Signals
Indicator
ENTA
PTLO
Relative Strength Index (RSI) 41.06 48.52
Support Level $12.09 $4.51
Resistance Level $15.52 $5.30
Average True Range (ATR) 0.81 0.29
MACD -0.15 -0.02
Stochastic Oscillator 4.86 38.40

Price Performance

Historical Comparison
ENTA
PTLO

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About PTLO Portillo's Inc.

Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.

Share on Social Networks: